Severn Trent Water has awarded a contract to Bluewater Bio International to provide its HYBACS wastewater treatment technology to upgrade the Ashbourne sewage treatment works (STW) in Derbyshire, UK.
Bluewater Bio received the order from Severn Trent's key framework contractor MWH Treatment. As part of the contract, Bluewater Bio will deliver four of its SMART unit reactors, which power the HYBACS process, to MWH.
Severn Trent Waste Water R&D manager Mark Jones said: "Following an extensive and lengthy on-site evaluation, the company is convinced HYBACS wastewater treatment technology could provide real cost effective solutions to the challenges. We believe that HYBACS has great potential, especially as a slot in process for the upgrading of existing sites due to its low operational cost and small additional hydraulic head requirements."
Bluewater Bio COO Adrian Harris said his company and Jones's R&D team collaborated during this evaluation period, in which the HYBACS plant demonstrated a very high performance and, in particular, the high level of nitrogen removal required both to meet and exceed the most stringent European treatment standards.
The upgrade at Ashbourne STW is being carried out as a result of a 45% increase in load to the works, due the to expansion by a major trader within the Ashbourne catchment. The overall upgrade is being carried out by MWH, and the works are scheduled to be complete in May 2012.
The order follows three years of close collaboration between Bluewater Bio and Severn Trent, during which time HYBACS was evaluated in a containerised demonstration plant at Coleshill STW in Birmingham.
Bluewater Bio is a provider of HYBACS, a high-performance and cost-effective wastewater treatment technology.
Caption: Bluewater Bio's HYBACS wastewater treatment technology will be used to upgrade sewage treatment works. Photo: Rjgalindo.
